Bausch Health Companies Inc. Operating Cash Flow
Bausch Health Companies Inc. (BHC) reported Operating Cash Flow of $900.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-07-30
- Bausch Health Companies Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $670.00M, a 131.83% increase year-over-year.
- Bausch Health Companies Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $230.00M, a 9.00% increase year-over-year.
- Bausch Health Companies Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $495.00M, a 17.64% decline year-over-year.
- Bausch Health Companies Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $405.00M, a 0.00% change year-over-year.
- Bausch Health Companies Inc. net cash provided by (used in) operating activities for fiscal 2025 was $1.40B, a 12.34% decline from fiscal 2024.
- Bausch Health Companies Inc. net cash provided by (used in) operating activities for fiscal 2024 was $1.60B, a 54.75% increase from fiscal 2023.
- Bausch Health Companies Inc. net cash provided by (used in) operating activities for fiscal 2023 was $1.03B.
- Bausch Health Companies Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$728.00M, a 151.05% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $670.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $900.00M 10-Q · filed 2026-07-30 | $1.40B derived: sum of 3 quarters · filed 2026-07-30 | $1.80B derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2026-03-31 | $230.00M 10-Q · filed 2026-04-30 | $725.00M derived: sum of 2 quarters · filed 2026-04-30 | $1.13B derived: sum of 3 quarters · filed 2026-04-30 | $1.42B derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-12-31 | $495.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $900.00M derived: sum of 2 quarters · filed 2026-02-19 | $1.19B derived: sum of 3 quarters · filed 2026-07-30 | $1.40B 10-K · filed 2026-02-19 | ||||
| 2025-09-30 | $405.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $694.00M derived: sum of 2 quarters · filed 2026-07-30 | $905.00M 10-Q · filed 2025-10-30 | $1.51B derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-06-30 | $289.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $500.00M 10-Q · filed 2026-07-30 | $1.10B derived: sum of 3 quarters · filed 2026-07-30 | $1.51B derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-03-31 | $211.00M 10-Q · filed 2026-04-30 | $812.00M derived: sum of 2 quarters · filed 2026-04-30 | $1.22B derived: sum of 3 quarters · filed 2026-04-30 | $1.60B derived: sum of 4 quarters · filed 2026-04-30 | ||||
| 2024-12-31 | $601.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $1.01B derived: sum of 2 quarters · filed 2026-02-19 | $1.39B derived: sum of 3 quarters · filed 2026-02-19 | $1.60B 10-K · filed 2026-02-19 | ||||
| 2024-09-30 | $405.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $785.00M derived: sum of 2 quarters · filed 2025-10-30 | $996.00M 10-Q · filed 2025-10-30 | $1.39B derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2024-06-30 | $380.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $591.00M 10-Q · filed 2025-07-31 | $981.00M derived: sum of 3 quarters · filed 2026-02-19 | $1.26B derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2024-03-31 | $211.00M 10-Q · filed 2025-05-01 | $601.00M derived: sum of 2 quarters · filed 2026-02-19 | $883.00M derived: sum of 3 quarters · filed 2026-02-19 | $1.09B derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2023-12-31 | $390.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $672.00M derived: sum of 2 quarters · filed 2026-02-19 | $878.00M derived: sum of 3 quarters · filed 2026-02-19 | $1.03B 10-K · filed 2026-02-19 | ||||
| 2023-09-30 | $282.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $488.00M derived: sum of 2 quarters · filed 2024-10-31 | $642.00M 10-Q · filed 2024-10-31 | $1.12B derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2023-06-30 | $206.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $360.00M 10-Q · filed 2024-08-01 | $835.00M derived: sum of 3 quarters · filed 2025-02-20 | -$428.00M derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2023-03-31 | $154.00M 10-Q · filed 2024-05-02 | $629.00M derived: sum of 2 quarters · filed 2025-02-20 | -$634.00M derived: sum of 3 quarters · filed 2025-02-20 | -$511.00M derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2022-12-31 | $475.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | -$788.00M derived: sum of 2 quarters · filed 2025-02-20 | -$665.00M derived: sum of 3 quarters · filed 2025-02-20 | -$728.00M 10-K · filed 2025-02-20 | ||||
| 2022-09-30 | -$1.26B derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$1.14B derived: sum of 2 quarters · filed 2023-11-02 | -$1.20B 10-Q · filed 2023-11-02 | -$1.18B derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-06-30 | $123.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $60.00M 10-Q · filed 2023-08-03 | $84.00M derived: sum of 3 quarters · filed 2024-02-22 | $648.00M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-03-31 | -$63.00M 10-Q · filed 2023-05-04 | -$39.00M derived: sum of 2 quarters · filed 2024-02-22 | $525.00M derived: sum of 3 quarters · filed 2024-02-22 | $920.00M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2021-12-31 | $24.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $588.00M derived: sum of 2 quarters · filed 2024-02-22 | $983.00M derived: sum of 3 quarters · filed 2024-02-22 | $1.43B 10-K · filed 2024-02-22 | ||||
| 2021-09-30 | $564.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $959.00M derived: sum of 2 quarters · filed 2022-11-03 | $1.40B 10-Q · filed 2022-11-03 | $1.80B derived: sum of 4 quarters · filed 2022-11-03 | ||||
| 2021-06-30 | $395.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $838.00M 10-Q · filed 2022-08-09 | $1.23B derived: sum of 3 quarters · filed 2022-08-09 | $1.49B derived: sum of 4 quarters · filed 2022-08-09 | ||||
| 2021-03-31 | $443.00M 10-Q · filed 2022-05-10 | $837.00M derived: sum of 2 quarters · filed 2022-05-10 | $1.09B derived: sum of 3 quarters · filed 2022-05-10 | $1.29B derived: sum of 4 quarters · filed 2022-05-10 | ||||
| 2020-12-31 | $394.00M 8-K · filed 2021-05-04 | $650.00M derived: sum of 2 quarters · filed 2021-05-04 | $850.00M derived: sum of 3 quarters · filed 2021-05-04 | $1.11B 10-K · filed 2023-02-23 | ||||
| 2020-09-30 | $256.00M 8-K · filed 2021-05-04 | $456.00M derived: sum of 2 quarters · filed 2021-05-04 | $717.00M 10-Q · filed 2021-11-02 | $951.00M derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2020-06-30 | $200.00M 8-K · filed 2021-05-04 | $461.00M 10-Q · filed 2021-08-03 | $695.00M derived: sum of 3 quarters · filed 2021-05-04 | $1.21B derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2020-03-31 | $261.00M 10-Q · filed 2021-05-04 | $495.00M derived: sum of 2 quarters · filed 2021-05-04 | $1.01B derived: sum of 3 quarters · filed 2021-05-04 | $1.35B derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2019-12-31 | $234.00M 8-K · filed 2021-05-04 | $749.00M derived: sum of 2 quarters · filed 2021-05-04 | $1.09B derived: sum of 3 quarters · filed 2021-05-04 | $1.50B 8-K · filed 2022-05-11 | ||||
| 2019-09-30 | $515.00M 8-K · filed 2021-05-04 | $854.00M derived: sum of 2 quarters · filed 2021-05-04 | $1.27B 10-Q · filed 2020-11-03 | $1.59B derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2019-06-30 | $339.00M 8-K · filed 2021-05-04 | $752.00M 10-Q · filed 2020-08-06 | $1.07B derived: sum of 3 quarters · filed 2021-05-04 | $1.59B derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2019-03-31 | $413.00M 8-K · filed 2021-05-04 | $732.00M derived: sum of 2 quarters · filed 2021-05-04 | $1.25B derived: sum of 3 quarters · filed 2021-05-04 | $1.48B derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2018-12-31 | $319.00M 10-K · filed 2020-02-19 | $841.00M derived: sum of 2 quarters · filed 2020-02-19 | $1.06B derived: sum of 3 quarters · filed 2020-02-19 | $1.50B 8-K · filed 2021-05-04 | ||||
| 2018-09-30 | $522.00M 10-K · filed 2020-02-19 | $744.00M derived: sum of 2 quarters · filed 2020-02-19 | $1.18B 10-Q · filed 2019-11-04 | $1.76B derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-06-30 | $222.00M 10-K · filed 2020-02-19 | $660.00M 10-Q · filed 2019-08-06 | $1.24B derived: sum of 3 quarters · filed 2020-02-19 | $1.73B derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-03-31 | $438.00M 10-K · filed 2020-02-19 | $1.02B derived: sum of 2 quarters · filed 2020-02-19 | $1.51B derived: sum of 3 quarters · filed 2020-02-19 | $1.77B derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2017-12-31 | $578.00M 10-K · filed 2019-02-20 | $1.07B derived: sum of 2 quarters · filed 2019-02-20 | $1.34B derived: sum of 3 quarters · filed 2019-02-20 | $2.29B 10-K · filed 2020-02-19 | ||||
| 2017-09-30 | $490.00M 10-K · filed 2019-02-20 | $758.00M derived: sum of 2 quarters · filed 2019-02-20 | $1.71B 10-Q · filed 2018-11-06 | $2.22B derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2017-06-30 | $268.00M 10-K · filed 2019-02-20 | $1.22B 10-Q · filed 2018-08-07 | $1.73B derived: sum of 3 quarters · filed 2019-02-20 | $2.30B derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2017-03-31 | $954.00M 10-K · filed 2019-02-20 | $1.47B derived: sum of 2 quarters · filed 2019-02-20 | $2.04B derived: sum of 3 quarters · filed 2019-02-20 | $2.48B derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2016-12-31 | $512.00M 8-K · filed 2018-08-10 | $513.00M 10-K · filed 2017-03-01 | $1.08B derived: sum of 2 quarters · filed 2018-08-10 | $1.53B derived: sum of 3 quarters · filed 2018-08-10 | $2.09B 10-K · filed 2019-02-20 | |||
| 2016-09-30 | $569.00M 8-K · filed 2018-08-10 | $1.02B derived: sum of 2 quarters · filed 2018-08-10 | $1.57B 10-Q · filed 2017-11-07 | $1.57B 10-Q · filed 2016-11-09 | $2.17B derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2016-06-30 | $449.00M 8-K · filed 2018-08-10 | $1.00B 10-Q · filed 2017-08-08 | $1.01B 10-Q · filed 2016-08-09 | $1.60B derived: sum of 3 quarters · filed 2018-08-10 | $2.34B derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2016-03-31 | $556.00M 8-K · filed 2018-08-10 | $558.10M 10-Q · filed 2016-06-07 | $1.15B derived: sum of 2 quarters · filed 2018-08-10 | $1.89B derived: sum of 3 quarters · filed 2018-08-10 | $2.31B derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2015-12-31 | $598.00M 10-K · filed 2017-03-01 | $562.30M 10-K · filed 2016-04-29 | $1.33B derived: sum of 2 quarters · filed 2017-03-01 | $1.75B derived: sum of 3 quarters · filed 2017-03-01 | $2.26B 8-K · filed 2018-08-10 | $2.20B 10-K · filed 2016-04-29 | ||
| 2015-09-30 | $733.00M 10-K · filed 2017-03-01 | $736.50M 10-Q · filed 2015-10-26 | $1.15B derived: sum of 2 quarters · filed 2017-03-01 | $1.66B 10-Q · filed 2016-11-09 | $1.64B 10-Q · filed 2015-10-26 | $2.48B derived: sum of 4 quarters · filed 2017-03-01 | ||
| 2015-06-30 | $418.00M 10-K · filed 2017-03-01 | $410.50M 10-Q · filed 2015-07-28 | $901.60M 10-Q · filed 2016-08-09 | $1.74B derived: sum of 3 quarters · filed 2017-03-01 | $2.36B derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-03-31 | $509.00M 10-K · filed 2017-03-01 | $491.10M 10-Q · filed 2015-04-30 | $1.32B derived: sum of 2 quarters · filed 2017-03-01 | $1.94B derived: sum of 3 quarters · filed 2017-03-01 | $2.32B derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2014-12-31 | $815.70M 10-K · filed 2016-04-29 | $1.43B derived: sum of 2 quarters · filed 2016-04-29 | $1.81B derived: sum of 3 quarters · filed 2016-04-29 | $2.31B 10-K · filed 2017-03-01 | $2.29B 10-K · filed 2015-02-25 | |||
| 2014-09-30 | $618.70M 10-K · filed 2016-04-29 | $994.70M derived: sum of 2 quarters · filed 2016-04-29 | $1.48B 10-K · filed 2016-04-29 | |||||
| 2014-06-30 | $376.00M 10-K · filed 2016-04-29 | $860.30M 10-K · filed 2016-04-29 | ||||||
| 2014-03-31 | $484.30M 10-K · filed 2016-04-29 | |||||||
| 2013-12-31 | $1.04B 10-K · filed 2016-04-29 | |||||||
| 2012-12-31 | $656.60M 10-K · filed 2015-02-25 | |||||||
| 2011-06-30 | $226.66M 10-Q · filed 2011-08-08 | $312.99M 10-Q · filed 2011-08-08 | $311.59M derived: sum of 3 quarters · filed 2011-08-08 | $422.51M derived: sum of 4 quarters · filed 2011-08-08 | ||||
| 2011-03-31 | $86.33M 10-Q · filed 2011-05-10 | $84.93M derived: sum of 2 quarters · filed 2011-05-10 | $195.85M derived: sum of 3 quarters · filed 2011-05-10 | $304.77M derived: sum of 4 quarters · filed 2011-08-08 | ||||
| 2010-12-31 | -$1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-28 | $109.53M derived: sum of 2 quarters · filed 2011-02-28 | $218.44M derived: sum of 3 quarters · filed 2011-08-08 | $263.19M 10-K · filed 2011-02-28 | ||||
| 2010-09-30 | $110.92M 10-Q · filed 2010-11-05 | $219.84M derived: sum of 2 quarters · filed 2011-08-08 | $264.59M 10-Q · filed 2010-11-05 | $392.24M derived: sum of 4 quarters · filed 2011-08-08 | ||||
| 2010-06-30 | $108.91M 10-Q · filed 2011-08-08 | $153.67M 10-Q · filed 2011-08-08 | $281.31M derived: sum of 3 quarters · filed 2011-08-08 | $370.51M derived: sum of 4 quarters · filed 2011-08-08 | ||||
| 2010-03-31 | $44.75M 10-Q · filed 2011-05-10 | $172.40M derived: sum of 2 quarters · filed 2011-05-10 | $261.60M derived: sum of 3 quarters · filed 2011-05-10 | $358.68M derived: sum of 4 quarters · filed 2011-05-10 | ||||
| 2009-12-31 | $127.65M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-28 | $216.84M derived: sum of 2 quarters · filed 2011-02-28 | $313.93M derived: sum of 3 quarters · filed 2011-02-28 | $360.90M 10-K · filed 2011-02-28 | ||||
| 2009-09-30 | $89.20M 10-Q · filed 2010-11-05 | $186.28M derived: sum of 2 quarters · filed 2010-11-05 | $233.25M 10-Q · filed 2010-11-05 | |||||
| 2009-06-30 | $97.08M 10-Q · filed 2010-08-06 | $144.05M 10-Q · filed 2010-08-06 | ||||||
| 2008-12-31 | $204.32M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |